Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Antithrombotic therapy after transcatheter aortic valve replacement--reply.

Mack M.

JAMA. 2014 Mar 26;311(12):1250-1. doi: 10.1001/jama.2014.1183. No abstract available.

PMID:
24668110
2.

Antithrombotic therapy after transcatheter aortic valve replacement.

Hough A, Woods D.

JAMA. 2014 Mar 26;311(12):1249-50. doi: 10.1001/jama.2014.1180. No abstract available.

PMID:
24668109
3.

Outcomes following transcatheter aortic valve replacement in the United States.

Mack MJ, Brennan JM, Brindis R, Carroll J, Edwards F, Grover F, Shahian D, Tuzcu EM, Peterson ED, Rumsfeld JS, Hewitt K, Shewan C, Michaels J, Christensen B, Christian A, O'Brien S, Holmes D; STS/ACC TVT Registry..

JAMA. 2013 Nov 20;310(19):2069-77. doi: 10.1001/jama.2013.282043.

PMID:
24240934
4.

Improving outlook for elderly patients with aortic stenosis.

Bonow RO.

JAMA. 2013 Nov 20;310(19):2045-7. doi: 10.1001/jama.2013.281825. No abstract available.

PMID:
24240930
5.

Clinical studies assessing transcatheter aortic valve replacement.

Raheem S, Popma JJ.

Methodist Debakey Cardiovasc J. 2012 Apr-Jun;8(2):13-8. Review. No abstract available.

7.

Tweedledum and Tweedledee? Meta-regression for 30-day all-cause mortality by predicted mortality in contemporary transcatheter aortic valve implantation studies.

Takagi H, Mizuno Y, Niwa M, Goto SN, Umemoto T; ALICE (All-Literature Investigation of Cardiovascular Evidence) Group..

Int J Cardiol. 2013 Oct 9;168(4):4572-4. doi: 10.1016/j.ijcard.2013.06.073. Epub 2013 Jul 23. No abstract available.

PMID:
23890901
8.

Device stratified comparison among transfemoral, transapical and transubclavian access for Transcatheter Aortic Valve Replacement (TAVR): a meta-analysis.

Garcia DC, Benjo A, Cardoso RN, Macedo FY, Chavez P, Aziz EF, Herzog E, Alam M, de Marchena E.

Int J Cardiol. 2014 Mar 15;172(2):e318-21. doi: 10.1016/j.ijcard.2013.12.162. Epub 2014 Jan 9. No abstract available.

PMID:
24485611
9.

Next-generation transcatheter heart valves: current trials in Europe and the USA.

Sinning JM, Werner N, Nickenig G, Grube E.

Methodist Debakey Cardiovasc J. 2012 Apr-Jun;8(2):9-12. Review.

10.

[Transcatheter aortic valve implantation (TAVI)].

Möllmann H, Kim WK, Walther T, Hamm C.

Internist (Berl). 2013 Dec;54(12):1469-81; quiz 1482-3. doi: 10.1007/s00108-013-3382-9. Review. German.

PMID:
24253389
11.

Transapical transcatheter aortic valve implantation vs conventional aortic valve replacement in high-risk patients with previous cardiac surgery: a propensity-score analysis.

Wilbring M, Tugtekin SM, Alexiou K, Simonis G, Matschke K, Kappert U.

Eur J Cardiothorac Surg. 2013 Jul;44(1):42-7. doi: 10.1093/ejcts/ezs680. Epub 2013 Jan 22.

PMID:
23345180
12.

Aortic valve disease.

Rayner J, Coffey S, Newton J, Prendergast BD.

Int J Clin Pract. 2014 Oct;68(10):1209-15. doi: 10.1111/ijcp.12471. Epub 2014 Jun 4.

PMID:
24898790
13.

Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators..

N Engl J Med. 2011 Jun 9;364(23):2187-98. doi: 10.1056/NEJMoa1103510. Epub 2011 Jun 5.

14.

Multidimensional MDCT angiography in the context of transcatheter aortic valve implantation.

Goenka AH, Schoenhagen P, Bolen MA, Desai MY.

AJR Am J Roentgenol. 2014 Oct;203(4):749-58. doi: 10.2214/AJR.13.12159. Review.

PMID:
25247940
15.

Implications of bicuspid aortic valves for transcatheter aortic valve implantation.

O'Sullivan CJ, Windecker S.

Circ Cardiovasc Interv. 2013 Jun;6(3):204-6. doi: 10.1161/CIRCINTERVENTIONS.113.000461. No abstract available.

16.

Neurological injury after transcatheter aortic valve implantation: are the trees falling silently or is our hearing impaired?

Browndyke JN, Mathew JP.

Circ Cardiovasc Interv. 2013 Dec;6(6):599-601. doi: 10.1161/CIRCINTERVENTIONS.113.001017. No abstract available.

17.

Room considerations with TAVR.

Kleiman N.

Methodist Debakey Cardiovasc J. 2012 Apr-Jun;8(2):19-21.

18.

Impact of varying degrees of renal dysfunction on transcatheter and surgical aortic valve replacement.

Nguyen TC, Babaliaros VC, Razavi SA, Kilgo PD, Guyton RA, Devireddy CM, Shults CC, Mavromatis K, Kanitkar M, Block P, Lerakis S, Thourani VH.

J Thorac Cardiovasc Surg. 2013 Dec;146(6):1399-406; discussion 13406-7. doi: 10.1016/j.jtcvs.2013.07.065. Epub 2013 Sep 24.

19.

Stroke complicating transcatheter aortic valve implantation: incidence, risk factors and outcome.

Leker RR, Eichel R, Verber A, Cohen JE, Lotan C, Danenberg HD.

Int J Stroke. 2013 Jun;8(4):235-9. doi: 10.1111/j.1747-4949.2012.00804.x. Epub 2012 Apr 18.

PMID:
22510242
20.

In which patients is transcatheter aortic valve replacement potentially better indicated than surgery for redo aortic valve disease? Long-term results of a 10-year surgical experience.

Pechlivanidis K, Onorati F, Petrilli G, Santini F, Milano A, Torre S, Calzaferri D, Mazzucco A, Faggian G.

J Thorac Cardiovasc Surg. 2014 Aug;148(2):500-8.e1. doi: 10.1016/j.jtcvs.2013.09.031. Epub 2013 Oct 30.

Supplemental Content

Support Center